Cargando…

Innovative intraoral cooling device better tolerated and equally effective as ice cooling

PURPOSE: Most of the patients who receive myeloablative therapy prior to stem cell transplantation develop oral mucositis (OM). This adverse reaction manifests as oral mucosal erythema and ulcerations and may require high doses of morphine for pain alleviation. OM may also interfere with food intake...

Descripción completa

Detalles Bibliográficos
Autores principales: Walladbegi, Java, Gellerstedt, Martin, Svanberg, Anncarin, Jontell, Mats
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676821/
https://www.ncbi.nlm.nih.gov/pubmed/28975429
http://dx.doi.org/10.1007/s00280-017-3434-2
_version_ 1783277134248148992
author Walladbegi, Java
Gellerstedt, Martin
Svanberg, Anncarin
Jontell, Mats
author_facet Walladbegi, Java
Gellerstedt, Martin
Svanberg, Anncarin
Jontell, Mats
author_sort Walladbegi, Java
collection PubMed
description PURPOSE: Most of the patients who receive myeloablative therapy prior to stem cell transplantation develop oral mucositis (OM). This adverse reaction manifests as oral mucosal erythema and ulcerations and may require high doses of morphine for pain alleviation. OM may also interfere with food intake and result in weight loss, a need for parenteral nutrition, and impaired quality of life. To date, there have been very few studies of evidence-based interventions for the prevention of OM. Cryotherapy, using ice chips, has been shown to reduce in an efficient manner the severity and extent of OM, although clinical applications are still limited due to several shortcomings, such as adverse tooth sensations, problems with infectious organisms in the water, nausea, and uneven cooling of the oral mucosa. The present proof-of-concept study was conducted to compare the tolerability, temperature reduction, and cooling distribution profiles of an intra-oral cooling device and ice chips in healthy volunteers who did not receive myeloablative treatment, and therefore, did not experience the symptoms of OM. METHODS: Twenty healthy volunteers used the cooling device and ice chips for a maximum of 60 min each, using a cross-over design. The baseline and final temperatures were measured at eight intra-oral locations using an infra-red thermographic camera. The thermographic images were analysed using two digital software packages. A questionnaire was used to assess the tolerability levels of the two interventions. RESULTS: The intra-oral cooling device was significantly better tolerated than the ice-chips (p = 0.0118). The two interventions were equally effective regarding temperature reduction and cooling distribution. CONCLUSIONS: The intra-oral cooling device shows superior tolerability in healthy volunteers. Furthermore, this study shows that temperature reduction and cooling distribution are achieved equally well using either method. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00280-017-3434-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5676821
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-56768212017-11-21 Innovative intraoral cooling device better tolerated and equally effective as ice cooling Walladbegi, Java Gellerstedt, Martin Svanberg, Anncarin Jontell, Mats Cancer Chemother Pharmacol Original Article PURPOSE: Most of the patients who receive myeloablative therapy prior to stem cell transplantation develop oral mucositis (OM). This adverse reaction manifests as oral mucosal erythema and ulcerations and may require high doses of morphine for pain alleviation. OM may also interfere with food intake and result in weight loss, a need for parenteral nutrition, and impaired quality of life. To date, there have been very few studies of evidence-based interventions for the prevention of OM. Cryotherapy, using ice chips, has been shown to reduce in an efficient manner the severity and extent of OM, although clinical applications are still limited due to several shortcomings, such as adverse tooth sensations, problems with infectious organisms in the water, nausea, and uneven cooling of the oral mucosa. The present proof-of-concept study was conducted to compare the tolerability, temperature reduction, and cooling distribution profiles of an intra-oral cooling device and ice chips in healthy volunteers who did not receive myeloablative treatment, and therefore, did not experience the symptoms of OM. METHODS: Twenty healthy volunteers used the cooling device and ice chips for a maximum of 60 min each, using a cross-over design. The baseline and final temperatures were measured at eight intra-oral locations using an infra-red thermographic camera. The thermographic images were analysed using two digital software packages. A questionnaire was used to assess the tolerability levels of the two interventions. RESULTS: The intra-oral cooling device was significantly better tolerated than the ice-chips (p = 0.0118). The two interventions were equally effective regarding temperature reduction and cooling distribution. CONCLUSIONS: The intra-oral cooling device shows superior tolerability in healthy volunteers. Furthermore, this study shows that temperature reduction and cooling distribution are achieved equally well using either method. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00280-017-3434-2) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-10-03 2017 /pmc/articles/PMC5676821/ /pubmed/28975429 http://dx.doi.org/10.1007/s00280-017-3434-2 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Walladbegi, Java
Gellerstedt, Martin
Svanberg, Anncarin
Jontell, Mats
Innovative intraoral cooling device better tolerated and equally effective as ice cooling
title Innovative intraoral cooling device better tolerated and equally effective as ice cooling
title_full Innovative intraoral cooling device better tolerated and equally effective as ice cooling
title_fullStr Innovative intraoral cooling device better tolerated and equally effective as ice cooling
title_full_unstemmed Innovative intraoral cooling device better tolerated and equally effective as ice cooling
title_short Innovative intraoral cooling device better tolerated and equally effective as ice cooling
title_sort innovative intraoral cooling device better tolerated and equally effective as ice cooling
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676821/
https://www.ncbi.nlm.nih.gov/pubmed/28975429
http://dx.doi.org/10.1007/s00280-017-3434-2
work_keys_str_mv AT walladbegijava innovativeintraoralcoolingdevicebettertoleratedandequallyeffectiveasicecooling
AT gellerstedtmartin innovativeintraoralcoolingdevicebettertoleratedandequallyeffectiveasicecooling
AT svanberganncarin innovativeintraoralcoolingdevicebettertoleratedandequallyeffectiveasicecooling
AT jontellmats innovativeintraoralcoolingdevicebettertoleratedandequallyeffectiveasicecooling